Presently, CAL 18 only warns about grapefruit as a result of its effect on the bioavailability of specific medicines in the selective inhibition of cytochrome P450 3A4 isoenzymes. However the product or service data (PI) For brand new medicines which might be substrates for CYP3A4 increasingly point out other fruits (further than just grapefruit) a